UTHealth Houston researchers developed an experimental peptide therapy that successfully targeted and killed metastatic cancer cells in mice.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Preclinical efficacy of experimental peptide therapy suggests a new target for metastatic breast cancer treatments
UTHealth Houston - Brown Foundation Institute Research Institution
Metastatic Breast Cancer Disease Target
Molecular Therapy Oncology Publication
Preclinical (Mouse Models) Research Stage